Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Who Decides How AI Enters Pathology
Laboratory management Digital and computational pathology Digital Pathology Voices in the Community Workforce Trends

Who Decides How AI Enters Pathology?

Liron Pantanowitz explains why validation, leadership, and real-world use matter more than performance metrics

By Jessica Allerton 06/12/2026 Discussion 4 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Institutions
  • Topic Commentary

Share

Clinical Scorecard: Who Decides How AI Enters Pathology?

At a Glance

CategoryDetail
Condition
Key MechanismsAI tools assist in identifying small metastatic foci in pathology slides.
Target Population
Care Setting

Key Highlights

  • Google AI's Lymph Node Assistant (LYNA) achieved high accuracy in detecting metastatic breast cancer.
  • Clinical validation in real-world settings is essential before routine use of AI tools.

Guideline-Based Recommendations

Diagnosis

  • AI tools should be validated in the local clinical environment before patient care.

Management

  • Implementation should start with a clear clinical need.

Monitoring & Follow-up

  • Ongoing monitoring for version changes or drift is necessary.

Risks

  • Human oversight is important to define when AI can be relied upon.

Patient & Prescribing Data

AI can support diagnostic tasks.

Clinical Best Practices

  • Ensure accurate annotation and establish consensus-based 'ground truth' for datasets.
  • Promote diverse and representative datasets to reduce bias.
  • Define expectations for explainability.

Related Resources & Content

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

    Newsletters

    Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

    Newsletter Signup Image

    About the Author(s)

    Jessica Allerton

    Deputy Editor, The Pathologist

    More Articles by Jessica Allerton

    Explore More in Pathology

    Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

    False

    Advertisement

    Recommended

    False

    Related Content

    Medicare Pathology Payments in 2021
    Laboratory management
    Medicare Pathology Payments in 2021

    January 26, 2024

    1 min read

    A national Medicare report extract for pathologists reveals where payments went in the US in 2021

    R-Tracker: The First of Its Kind
    Laboratory management
    R-Tracker: The First of Its Kind

    December 29, 2021

    1 min read

    Milestone is committed to enhancing patient safety with a new disruptive technology

    The Pathologist’s 2016 Power List
    Laboratory management
    The Pathologist’s 2016 Power List

    October 18, 2016

    1 min read

    Let’s celebrate the successes of our field by shining a spotlight on the next generation.

    The Times They Are A-Changin’
    Laboratory management
    The Times They Are A-Changin’

    October 21, 2016

    1 min read

    Or at least I hope they are, but I need your help…

    Affiliations:

    Specialties:

    Areas of Expertise:

    Contributions:

    False

    The Pathologist
    Subscribe

    About

    • About Us
    • Work at Conexiant Europe
    • Terms and Conditions
    • Privacy Policy
    • Advertise With Us
    • Contact Us

    Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.